Please enable JavaScript to continue using this application.

Compare $FRMM vs $XBIT | Chartloom

Compare

$FRMM vs $XBIT

Forum Markets, Inc · XBiotech Inc

FRMM

Forum Markets, Inc

XBIT

XBiotech Inc

Compare $FRMM vs $XBIT

Comparing Forum Markets, Inc and XBiotech Inc

FRMMForum Markets, Inc

XBITXBiotech Inc

FRMMForum Markets, Inc

Market cap

$59M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.70x

Rev growth (TTM)

—

YTD performance

-12.3%

52W performance

-80.7%

FCF yield

-124.7%

XBITXBiotech Inc

Market cap

$70M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.8%

52W performance

-14.9%

FCF yield

-58.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FRMM

XBIT

Detailed metrics comparison

FRMM

Forum Markets, Inc

XBIT

XBiotech Inc

Market Cap

FRMM$59M

XBIT$70M

Enterprise Value

FRMM$59M

XBIT$-40M

Price

FRMM$4.48

XBIT$2.29

P/E Ratio

FRMMN/A

XBITN/A

P/S Ratio

FRMM5.49x

XBIT16.50x

EV/Sales

FRMM5.49x

XBIT-10.81x

EV/EBITDA

FRMM0.00x

XBIT-0.06x

P/B Ratio

FRMM0.27x

XBIT0.52x

P/FCF Ratio

FRMMN/A

XBITN/A

EV/FCF

FRMM-0.80x

XBIT0.97x

PEG Ratio

FRMMN/A

XBITN/A

Forward P/E (NTM)

FRMMN/A

XBITN/A

Forward P/S (NTM)

FRMM1.70x

XBITN/A

Revenue (TTM)

FRMM$11M

XBIT$0

Revenue Growth (YoY)

FRMMN/A

XBITN/A

Forward Rev Growth

FRMM132.9%

XBIT0.0%

Gross Margin (TTM)

FRMM3.7%

XBIT83.8%

Operating Margin (TTM)

FRMM0.0%

XBIT0.0%

EBITDA Margin (TTM)

FRMM-122.2%

XBIT0.0%

Net Margin (TTM)

FRMM-4971.8%

XBIT0.0%

FCF Margin (TTM)

FRMM-684.9%

XBITN/A

Net Income (TTM)

FRMM$-536M

XBIT$-45M

FCF (TTM)

FRMM$-74M

XBIT$-41M

EPS (TTM)

FRMM-$31.38

XBIT-$1.48

ROE (TTM)

FRMM-25831.0%

XBIT-3162.0%

ROA (TTM)

FRMM-13469.0%

XBIT-3029.0%

ROIC (TTM)

FRMM-14374.0%

XBIT-3162.0%

Cash

FRMM$0

XBIT$110M

Debt

FRMM$0

XBIT$0

Net Cash/Debt

FRMM$0

XBIT$110M

Current Ratio (TTM)

FRMM0.33x

XBIT33.15x

Quick Ratio (TTM)

FRMM0.22x

XBIT32.75x

Debt/Equity (TTM)

FRMM0.24x

XBIT0.00x

Debt/Assets (TTM)

FRMM0.0%

XBIT0.0%

Interest Coverage (TTM)

FRMMN/A

XBITN/A

Net Debt/EBITDA (TTM)

FRMM0.00x

XBIT0.00x

Beta

FRMM1.66

XBIT0.73

52W Performance

FRMM-80.7%

XBIT-14.9%

YTD Performance

FRMM-12.3%

XBIT-3.8%

% from 52W High

FRMM-81.7%

XBIT-33.4%

% from 52W Low

FRMM154.5%

XBIT9.6%

Asset Turnover (TTM)

FRMM0.00x

XBIT0.02x

FCF Yield (TTM)

FRMM-124.7%

XBIT-58.5%

Earnings Yield (TTM)

FRMM-904.9%

XBIT-64.6%

Dividend Yield (TTM)

FRMMN/A

XBITN/A

Rule of 40

FRMM-684.9

XBIT0.0

EV/GP/RG

FRMM0.67

XBITN/A

Ticker research

View FRMM research View XBIT research

Metric	FRMM Forum Markets, Inc	XBIT XBiotech Inc
Market & Valuation
Market Cap	$59M	$70M
Enterprise Value	$59M	$-40M
Price	$4.48	$2.29
P/E Ratio	N/A	N/A
P/S Ratio	5.49x	16.50x
EV/Sales	5.49x	-10.81x
EV/EBITDA	0.00x	-0.06x
P/B Ratio	0.27x	0.52x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.80x	0.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.70x	N/A
Revenue & Growth
Revenue (TTM)	$11M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	132.9%	0.0%
Profitability
Gross Margin (TTM)	3.7%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-122.2%	0.0%
Net Margin (TTM)	-4971.8%	0.0%
FCF Margin (TTM)	-684.9%	N/A
Net Income (TTM)	$-536M	$-45M
FCF (TTM)	$-74M	$-41M
EPS (TTM)	-$31.38	-$1.48
ROE (TTM)	-25831.0%	-3162.0%
ROA (TTM)	-13469.0%	-3029.0%
ROIC (TTM)	-14374.0%	-3162.0%
Financial Health
Cash	$0	$110M
Debt	$0	$0
Net Cash/Debt	$0	$110M
Current Ratio (TTM)	0.33x	33.15x
Quick Ratio (TTM)	0.22x	32.75x
Debt/Equity (TTM)	0.24x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	0.73
52W Performance	-80.7%	-14.9%
YTD Performance	-12.3%	-3.8%
% from 52W High	-81.7%	-33.4%
% from 52W Low	154.5%	9.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-124.7%	-58.5%
Earnings Yield (TTM)	-904.9%	-64.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-684.9	0.0
EV/GP/RG	0.67	N/A
Ticker research	View FRMM research	View XBIT research

Valuation

P/S Ratio

FRMM

5.49x

XBIT

16.50x

EV/FCF

FRMM

-0.80x

XBIT

0.97x

Growth & revenue

Forward Revenue Growth

FRMM

132.9%

XBIT

0.0%

Profitability & performance

Gross Margin

XBIT

83.8%

FRMM

3.7%

ROE

XBIT

-3162.0%

FRMM

-25831.0%

FCF Yield %

XBIT

-58.5%

FRMM

-124.7%

52-Week Performance

XBIT

-14.9%

FRMM

-80.7%

Detailed metrics comparison

FRMM

Forum Markets, Inc

XBIT

XBiotech Inc

Market Cap

FRMM$59M

XBIT$70M

Enterprise Value

FRMM$59M

XBIT$-40M

Price

FRMM$4.48

XBIT$2.29

P/E Ratio

FRMMN/A

XBITN/A

P/S Ratio

FRMM5.49x

XBIT16.50x

EV/Sales

FRMM5.49x

XBIT-10.81x

EV/EBITDA

FRMM0.00x

XBIT-0.06x

P/B Ratio

FRMM0.27x

XBIT0.52x

P/FCF Ratio

FRMMN/A

XBITN/A

EV/FCF

FRMM-0.80x

XBIT0.97x

PEG Ratio

FRMMN/A

XBITN/A

Forward P/E (NTM)

FRMMN/A

XBITN/A

Forward P/S (NTM)

FRMM1.70x

XBITN/A

Revenue (TTM)

FRMM$11M

XBIT$0

Revenue Growth (YoY)

FRMMN/A

XBITN/A

Forward Rev Growth

FRMM132.9%

XBIT0.0%

Gross Margin (TTM)

FRMM3.7%

XBIT83.8%

Operating Margin (TTM)

FRMM0.0%

XBIT0.0%

EBITDA Margin (TTM)

FRMM-122.2%

XBIT0.0%

Net Margin (TTM)

FRMM-4971.8%

XBIT0.0%

FCF Margin (TTM)

FRMM-684.9%

XBITN/A

Net Income (TTM)

FRMM$-536M

XBIT$-45M

FCF (TTM)

FRMM$-74M

XBIT$-41M

EPS (TTM)

FRMM-$31.38

XBIT-$1.48

ROE (TTM)

FRMM-25831.0%

XBIT-3162.0%

ROA (TTM)

FRMM-13469.0%

XBIT-3029.0%

ROIC (TTM)

FRMM-14374.0%

XBIT-3162.0%

Cash

FRMM$0

XBIT$110M

Debt

FRMM$0

XBIT$0

Net Cash/Debt

FRMM$0

XBIT$110M

Current Ratio (TTM)

FRMM0.33x

XBIT33.15x

Quick Ratio (TTM)

FRMM0.22x

XBIT32.75x

Debt/Equity (TTM)

FRMM0.24x

XBIT0.00x

Debt/Assets (TTM)

FRMM0.0%

XBIT0.0%

Interest Coverage (TTM)

FRMMN/A

XBITN/A

Net Debt/EBITDA (TTM)

FRMM0.00x

XBIT0.00x

Beta

FRMM1.66

XBIT0.73

52W Performance

FRMM-80.7%

XBIT-14.9%

YTD Performance

FRMM-12.3%

XBIT-3.8%

% from 52W High

FRMM-81.7%

XBIT-33.4%

% from 52W Low

FRMM154.5%

XBIT9.6%

Asset Turnover (TTM)

FRMM0.00x

XBIT0.02x

FCF Yield (TTM)

FRMM-124.7%

XBIT-58.5%

Earnings Yield (TTM)

FRMM-904.9%

XBIT-64.6%

Dividend Yield (TTM)

FRMMN/A

XBITN/A

Rule of 40

FRMM-684.9

XBIT0.0

EV/GP/RG

FRMM0.67

XBITN/A

Ticker research

View FRMM research View XBIT research

Metric	FRMM Forum Markets, Inc	XBIT XBiotech Inc
Market & Valuation
Market Cap	$59M	$70M
Enterprise Value	$59M	$-40M
Price	$4.48	$2.29
P/E Ratio	N/A	N/A
P/S Ratio	5.49x	16.50x
EV/Sales	5.49x	-10.81x
EV/EBITDA	0.00x	-0.06x
P/B Ratio	0.27x	0.52x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.80x	0.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.70x	N/A
Revenue & Growth
Revenue (TTM)	$11M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	132.9%	0.0%
Profitability
Gross Margin (TTM)	3.7%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-122.2%	0.0%
Net Margin (TTM)	-4971.8%	0.0%
FCF Margin (TTM)	-684.9%	N/A
Net Income (TTM)	$-536M	$-45M
FCF (TTM)	$-74M	$-41M
EPS (TTM)	-$31.38	-$1.48
ROE (TTM)	-25831.0%	-3162.0%
ROA (TTM)	-13469.0%	-3029.0%
ROIC (TTM)	-14374.0%	-3162.0%
Financial Health
Cash	$0	$110M
Debt	$0	$0
Net Cash/Debt	$0	$110M
Current Ratio (TTM)	0.33x	33.15x
Quick Ratio (TTM)	0.22x	32.75x
Debt/Equity (TTM)	0.24x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	0.73
52W Performance	-80.7%	-14.9%
YTD Performance	-12.3%	-3.8%
% from 52W High	-81.7%	-33.4%
% from 52W Low	154.5%	9.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-124.7%	-58.5%
Earnings Yield (TTM)	-904.9%	-64.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-684.9	0.0
EV/GP/RG	0.67	N/A
Ticker research	View FRMM research	View XBIT research